5-HT2B receptor blockade attenuates β-adrenergic receptor-stimulated myocardial remodeling in rats via inhibiting apoptosis: Role of MAPKs and HSPs

Apoptosis

Volumn 20, Issue 4, 2015, Pages 455-465

  Bharti, Saurabh ^a   Rani, Neha ^a   Bhatia, Jagriti ^a   Arya, Dharamvir Singh ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

5 HT2B; Apoptosis; Autophagy; Isoproterenol; MAPKs, HSPs; Myocardial remodeling; SB 204741

Indexed keywords

ALPHA CRYSTALLIN; BECLIN 1; BETA ADRENERGIC RECEPTOR; BETA CRYSTALLIN; CASPASE 3; CYCLOOXYGENASE 2; CYTOCHROME C; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 65; HEAT SHOCK PROTEIN 70; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN BAX; SB 204741; SEROTONIN 2 ANTAGONIST; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; SEROTONIN 2B RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; AUTOPHAGY; BODY WEIGHT; CONTROLLED STUDY; DRUG EFFECT; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART PROTECTION; HEART VENTRICLE FUNCTION; HEART WEIGHT; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; ISOPROTERENOL INDUCED MYOCARDIAL REMODELING; ISOPROTERENOL-INDUCED MYOCARDIAL INFARCTION; LIPID PEROXIDATION; MALE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UPREGULATION; ANIMAL; CYTOLOGY; DRUG EFFECTS; ENZYMOLOGY; GENETICS; HEART; HEART MUSCLE; METABOLISM; SIGNAL TRANSDUCTION; WISTAR RAT;

RATTUS;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; APOPTOSIS; CASPASE 3; HEART; HEAT-SHOCK PROTEINS; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; MYOCARDIUM; RATS; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT2B; RECEPTORS, ADRENERGIC, BETA; SIGNAL TRANSDUCTION;

EID: 84924114114     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-014-1083-z     Document Type: Article

References (43)

1. Murphy E, Steenbergen C (2008) Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol Rev 88:581-609 10.1152/physrev.00024.2007 3199571 1:CAS:528:DC%2BD1cXls1KhsL8%3D 18391174
2. Balakumar P, Jagadeesh G (2010) Multifarious molecular signaling cascades of cardiac hypertrophy: can the muddy waters be cleared? Pharmacol Res 62:365-383 10.1016/j.phrs.2010.07.003 1:CAS:528:DC%2BC3cXht1Wmt7jL 20643208
3. Rose BA, Force T, Wang Y (2010) Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale. Physiol Rev 90:1507-1546 10.1152/physrev.00054.2009 1:CAS:528:DC%2BC3cXhsFSqtbjL 20959622
4. Willis MS, Patterson C (2010) Hold me tight: role of the heat shock protein family of chaperones in cardiac disease. Circulation 122:1740-1751 10.1161/CIRCULATIONAHA.110.942250 2976481 20975010
5. Snoeckx LH, Cornelussen RN, Van Nieuwenhoven FA, Reneman RS, Van Der Vusse GJ (2001) Heat shock proteins and cardiovascular pathophysiology. Physiol Rev 81:1461-1497 1:CAS:528:DC%2BD38XislCqsQ%3D%3D 11581494
6. Liang Q, Molkentin JD (2003) Redefining the roles of p38 and JNK signaling in cardiac hypertrophy: dichotomy between cultured myocytes and animal models. J Mol Cell Cardiol 35:1385-1394 10.1016/j.yjmcc.2003.10.001 1:CAS:528:DC%2BD3sXpsVSnsL8%3D 14654364
7. Bueno OF, Molkentin JD (2002) Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death. Circ Res 91:776-781 10.1161/01.RES.0000038488.38975.1A 1:CAS:528:DC%2BD38XotFKjsr4%3D 12411391
8. Martin JL, Mestril R, Hilal-Dandan R, Brunton LL, Dillmann WH (1997) Small heat shock proteins and protection against ischemic injury in cardiac myocytes. Circulation 96:4343-4348 10.1161/01.CIR.96.12.4343 1:CAS:528:DyaK1cXitlKrug%3D%3D 9416902
9. Ghayour-Mobarhan M, Saber H, Ferns GA (2012) The potential role of heat shock protein 27 in cardiovascular disease. Clin Chim Acta 413:15-24 10.1016/j.cca.2011.04.005 1:CAS:528:DC%2BC3MXhsFOhtbrM 21514288
10. Ghayour-Mobarhan M, Rahsepar AA, Tavallaie S, Rahsepar S, Ferns GA (2009) The potential role of heat shock proteins in cardiovascular disease: evidence from in vitro and in vivo studies. Adv Clin Chem 48:27-72 10.1016/S0065-2423(09)48002-8 1:CAS:528:DC%2BD1MXhs1Wis7bI 19803414
11. Gustafsson AB, Gottlieb RA (2009) Autophagy in ischemic heart disease. Circ Res 104:150-158 10.1161/CIRCRESAHA.108.187427 2765251 1:CAS:528:DC%2BD1MXntFahsA%3D%3D 19179668
12. Nishida K, Kyoi S, Yamaguchi O, Sadoshima J, Otsu K (2009) The role of autophagy in the heart. Cell Death Differ 16:31-38 10.1038/cdd.2008.163 1:CAS:528:DC%2BD1cXhsV2it7%2FP 19008922
13. Ramage AG, Villalón CM (2008) 5-hydroxytryptamine and cardiovascular regulation. Trends Pharmacol Sci 29:472-481 10.1016/j.tips.2008.06.009 1:CAS:528:DC%2BD1cXhtVKnurrL 19086344
14. Nebigil CG, Choi DS, Dierich A, Hickel P, Le Meur M et al (2000) Serotonin 2B receptor is required for heart development. Proc Natl Acad Sci USA 97:9508-9513 10.1073/pnas.97.17.9508 16895 1:CAS:528:DC%2BD3cXmtVensLg%3D 10944220
15. Monassier L, Laplante MA, Jaffré F, Bousquet P, Maroteaux L et al (2008) Serotonin 5-HT(2B) receptor blockade prevents reactive oxygen species-induced cardiac hypertrophy in mice. Hypertension 52:301-307 10.1161/HYPERTENSIONAHA.107.105551 1:CAS:528:DC%2BD1cXosFyqu7s%3D 18591460
16. Launay JM, Hervé P, Peoc'h K, Tournoi C, Callebert J et al (2002) Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension. Nat Med 8:1129-1135 10.1038/nm764 1:CAS:528:DC%2BD38XnsVGrt7Y%3D 12244304
17. Nebigil CG, Jaffré F, Messaddeq N, Hickel P, Monassier L et al (2003) Overexpression of the serotonin 5-HT2B receptor in heart leads to abnormal mitochondrial function and cardiac hypertrophy. Circulation 107:3223-3229 10.1161/01.CIR.0000074224.57016.01 1:CAS:528:DC%2BD3sXkslKgt7w%3D 12810613
18. Liang YJ, Lai LP, Wang BW, Juang SJ, Chang CM et al (2006) Mechanical stress enhances serotonin 2B receptor modulating brain natriuretic peptide through nuclear factor-κB in cardiomyocytes. Cardiovasc Res 72:303-312 10.1016/j.cardiores.2006.08.003 1:CAS:528:DC%2BD28XhtVygsLnM 16962085
19. Ojaimi C, Qanud K, Hintze TH, Recchia FA (2007) Altered expression of a limited number of genes contributes to cardiac decompensation during chronic ventricular tachypacing in dogs. Physiol Genomics 29:76-83 10.1152/physiolgenomics.00159.2006 1:CAS:528:DC%2BD2sXktVaru7c%3D 17164392
20. Robiolio PA, Rigolin VH, Wilson JS, Harrison JK, Sanders LL et al (1995) Carcinoid heart disease. Correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echocardiography. Circulation 92:790-795 10.1161/01.CIR.92.4.790 1:STN:280:DyaK2MzmvVyisw%3D%3D 7641358
21. Fonfara S, Hetzel U, Oyama MA, Kipar A (2014) The potential role of myocardial serotonin receptor 2B expression in canine dilated cardiomyopathy. Vet J 199:406-412 10.1016/j.tvjl.2013.12.003 1:CAS:528:DC%2BC2cXltl2nsLs%3D 24440442
22. Oxford AW, Borman RA, Coleman RA, Clark KL, Hynd G et al (2005) USPTO Application 20050176791
23. Watts SW, Fink GD (1999) 5-HT2B-receptor antagonist LY-272015 is antihypertensive in DOCA-salt-hypertensive rats. Am J Physiol 276:H944-H952 1:CAS:528:DyaK1MXit1ams7k%3D 10070078
24. Forbes IT, Jones GE, Murphy OE, Holland V, Baxter GS (1995) N-(1-methyl-5-indolyl)-N'-(3-methyl-5-isothiazolyl) urea: a novel, high-affinity 5-HT2B receptor antagonist. J Med Chem 38:855-857 10.1021/jm00006a001 1:CAS:528:DyaK2MXktFeiurc%3D 7699699
25. Bai CF, Liu JC, Zhao R, Cao W, Liu SB et al (2010) Role of 5-HT2B receptors in cardiomyocyte apoptosis in noradrenaline-induced cardiomyopathy in rats. Clin Exp Pharmacol Physiol 37:e145-e151 10.1111/j.1440-1681.2010.05388.x 1:CAS:528:DC%2BC3cXpsVOjsLc%3D 20374255
26. Moron MS, Depierre JW, Mannervik B (1979) Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta 582:67-78 10.1016/0304-4165(79)90289-7 1:CAS:528:DyaE1MXhtVSkurw%3D 760819
27. Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351-358 10.1016/0003-2697(79)90738-3 1:CAS:528:DyaE1MXksFaisbk%3D 36810
28. Marklund S, Marklund G (1974) Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 47:469-474 10.1111/j.1432-1033.1974.tb03714.x 1:CAS:528:DyaE2MXhtlGm 4215654
29. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS et al (1982) Analysis of nitrate, nitrite, and [15 N] nitrate in biological fluids. Anal Biochem 126:131-138 10.1016/0003-2697(82)90118-X 1:CAS:528:DyaL38XlvFGgtLY%3D 7181105
30. Goyal S, Bharti S, Sahoo KC, Sharma AK, Arya DS (2011) Valsartan, an angiotensin II receptor blocker, attenuates cardiac dysfunction and oxidative stress in isoproterenol-induced cardiotoxicity. Cardiovasc Toxicol 11:148-156 10.1007/s12012-011-9108-0 1:CAS:528:DC%2BC3MXlsFGqs7c%3D 21380857
31. Rani N, Bharti S, Manchanda M, Nag TC, Ray R et al (2013) Regulation of heat shock proteins 27 and 70, p-Akt/p-eNOS and MAPKs by naringin dampens myocardial injury and dysfunction in vivo after ischemia/reperfusion. PLoS ONE 8:e82577 10.1371/journal.pone.0082577 3855773 24324809
32. Kondo T, Ogawa Y, Sugiyama S, Ito T, Satake T et al (1987) Mechanism of isoproterenol induced myocardial damage. Cardiovasc Res 21:248-254 10.1093/cvr/21.4.248 1:CAS:528:DyaL2sXktVSmtbw%3D 3652091
33. Pfeifer U, Fohr J, Wilhelm W, Dammrich J (1987) Short-term inhibition of cardiac cellular autophagy by isoproterenol. J Mol Cell Cardiol 19:1179-1184 10.1016/S0022-2828(87)80528-X 1:CAS:528:DyaL1cXht1Cgs70%3D 3443985
34. Ullmer C, Boddeke HG, Schmuck K, Lübbert H (1996) 5-HT2B receptor-mediated calcium release from ryanodine-sensitive intracellular stores in human pulmonary artery endothelial cells. Br J Pharmacol 117:1081-1088 10.1111/j.1476-5381.1996.tb16700.x 1909758 1:CAS:528:DyaK28XitVentbg%3D 8882600
35. GorzaL Menabò R, Vitadello M, Bergamini CM, Di Lisa F (1996) Cardiomyocyte troponin T immunoreactivity is modified by cross-linking resulting from intracellular calcium overload. Circulation 93:1896-1904 10.1161/01.CIR.93.10.1896
36. Mounier N, Arrigo AP (2002) Actin cytoskeleton and small heat shock proteins: how do they interact? Cell Stress Chaperones 7:167-176 10.1379/1466-1268(2002)007<0167:ACASHS>2.0.CO;2 514814 1:CAS:528:DC%2BD38XptV2gsL0%3D 12380684
37. Shingala JR, Balaraman R (2005) Antihypertensive effect of 5-HT1A agonist buspirone and 5-HT2B antagonists in experimentally induced hypertension in rats. Pharmacology 73:129-139 10.1159/000082114 1:CAS:528:DC%2BD2MXhtVamtrs%3D 15539790
38. Mukhopadhyay S, Panda PK, Sinha N, Das DN, Bhutia SK (2014) Autophagy and apoptosis: where do they meet? Apoptosis 19:555-566 10.1007/s10495-014-0967-2 1:CAS:528:DC%2BC2cXpvVOgsg%3D%3D 24415198
39. Zhuo XZ, Wu Y, Ni YJ, Liu JH, Gong M et al (2013) Isoproterenol instigates cardiomyocyte apoptosis and heart failure via AMPK inactivation-mediated endoplasmic reticulum stress. Apoptosis 18:800-810 10.1007/s10495-013-0843-5 1:CAS:528:DC%2BC3sXoslWjtLc%3D 23620435
40. JaffréF Callebert J, Sarre A, Etienne N, Nebigil CG et al (2004) Involvement of the serotonin 5-HT2B receptor in cardiac hypertrophy linked to sympathetic stimulation: control of interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha cytokine production by ventricular fibroblasts. Circulation 110:969-974 10.1161/01.CIR.0000139856.20505.57
41. Djavaheri-Mergny M, Codogno P (2007) Autophagy joins the game to regulate NF-kappaB signaling pathways. Cell Res 17:576-577 10.1038/cr.2007.58 1:CAS:528:DC%2BD2sXns1ylsbg%3D 17632549
42. Djavaheri-Mergny M, Amelotti M, Mathieu J, Besancon F, Bauvy C et al (2007) Regulation of autophagy by NFkappaB transcription factor and reactive oxygen species. Autophagy 3:390-392 10.4161/auto.4248 1:CAS:528:DC%2BD2sXhtVGrtb7M 17471012
43. Mei Y, Thompson MD, Cohen RA, Tong X (2014) Autophagy and oxidative stress in cardiovascular diseases. Biochim Biophys Acta. doi: 10.1016/j.bbadis.2014.05.005; [Epub ahead of print]